
KCAS Bio will participate in the AMP 2025 Annual Meeting & Expo, taking place November 11-15 in Boston, MA. The AMP 2025 Annual Meeting brings together industry leaders and experts focused on advancing molecular diagnostics and precision medicine. The event covers the latest innovations in biomarker discovery, genomic testing, assay…

KCAS Bio will participate in AAPS 2025 PharmSci 360, taking place November 9-12 in San Antonio, TX. AAPS 2025 PharmSci 360 gathers industry professionals for a conference that covers the full spectrum of drug development. Topics will cover preclinical research, bioanalytics, clinical pharmacology, formulation, manufacturing, and regulatory science. These topics…

KCAS Bio will be participating in Society for Immunotherapy of Cancer (SITC) 2025, taking place on November 5-9 in National Harbor, MD. SITC 2025 convenes researchers, clinicians, and biopharmaceutical developers to explore the latest breakthroughs in immune-based cancer treatments. These field experts will discuss cutting-edge research and clinical needs within…

KCAS Bio will attend the ESMO Congress 2025, taking place in Berlin, Germany, on October 17-21. ESMO Congress brings together a diverse community in the oncology field to exchange knowledge, spotlight innovation, and shape the future of cancer care on a global scale. The meeting is an opportunity to connect…

KCAS Bio will be attending the NCCG Annual Meeting 2025, taking place in San Francisco on September 22. This gathering, hosted by NorCal Cytometry Group, unites professionals across the scientific, regulatory, and biotech communities who are interested in the advancements in the field of flow cytometry. The annual meeting will…

KCAS Bio will be attending MetroFlow 2025 Annual Meeting, taking place October 23 in New York, NY. The MetroFlow 2025 Annual Meeting brings together a dedicated community of flow cytometry professionals, including core facility directors, technical experts, researchers, and service providers. As such, this gathering provides a collaborative environment to…

KCAS Bio will be participating in Nordic Life Science Days (NLSDays) 2025, taking place October 13-14 in Gothenburg, Sweden. The conference focuses on early-stage drug development, partnerships, and innovation within the life sciences sector. Hosted by SwedenBIO, NLSDays brings together top scientists and business developers from across Europe to explore…

KCAS Bio will be participating in the Immunogenicity & Bioassay Summit 2025, taking place October 7-10 in Alexandria, VA. This annual summit, hosted by the Cambridge Healthtech Institute, brings together leaders in immunogenicity assessment, bioassay development, and translational science to explore emerging strategies in drug development. With focused tracks on…

In the ever-evolving landscape of drug development, biomarkers have emerged as critical tools for the mechanism of action, early proof of mechanism, safety, predictive, efficacy, and monitoring treatment response. As the field advances, two major classes of biomarkers have come to the forefront: soluble biomarkers and cellular biomarkers. While…

Join KCAS Bio at Applied Pharmaceutical Analysis (APA) 2025, taking place October 6-8 in Cambridge, Massachusetts. This scientific meeting, hosted by The Boston Society features three days of expert-led workshops on Regulated Bioanalysis, Discovery Bioanalysis, and Mechanistic ADME. The Mechanistic ADME track explores innovative topics such as PROTACs, molecular…

In the process of drug discovery, an IC₅₀ assay serves as a pivotal component in the development of cutting-edge therapeutics. An effective assay can quantify the potency of compounds, enable side-by-side comparisons with competing compounds, and track how a compound performs over time. Quantifying compound inhibition also assists with pre-clinical…

Join KCAS Bio at the 2025 Festival of Biologics, taking place from September 30 to October 2 in Basel, Switzerland. This festival, hosted by Terrapinn, brings together global stakeholders across pharma, biotech, academia, regulation, and investment to explore the discovery, development, manufacturing and commercialization of biologic therapies. During presentations, panels,…